Press Releases

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved XOFLUZA™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. XOFLUZA is a first-in-class, single-dose oral medicine with a novel propose

DUBLIN--(BUSINESS WIRE)-- The "US Allergic Rhinitis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Allergic Rhinitis Market and Competitive Landscape - 2018, provides comprehensive insights into Allergic Rhinitis pipeline, epidemiology, market

DUBLIN--(BUSINESS WIRE)-- The "US Pompe's Disease Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Pompe's Disease Market and Competitive Landscape - 2018, provides comprehensive insights into Pompe's Disease pipeline, epidemiology,

DUBLIN--(BUSINESS WIRE)-- The "US Kaposi's Sarcoma Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Kaposi's Sarcoma Market and Competitive Landscape - 2018, provides comprehensive insights into Kaposi's Sarcoma pipeline, epidemiolog

DUBLIN--(BUSINESS WIRE)-- The "US Wilson's Disease Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Wilson's Disease Market and Competitive Landscape - 2018, provides comprehensive insights into Wilson's Disease pipeline, epidemiology, market

DUBLIN--(BUSINESS WIRE)-- The "US Phenylketonuria Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Phenylketonuria Market and Competitive Landscape - 2018, provides comprehensive insights into Phenylketonuria pipeline, epidemiology,

DUBLIN--(BUSINESS WIRE)-- The "US Bile Duct Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Bile Duct Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Bile Duct Cancer pipeline, epidemiology, market v

ST. HELIER, Jersey--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today the retirement of Novocure founder Professor Yoram Palti, MD, PhD, and director Louis J. Lavigne, Jr. from the board of directors effective October 24, 2018. Professor Palti invented Tumor Treating Fields and founded Novocure in 2000. He serves as the company’s Chief Technology Officer (CTO) and has been a director of

DUBLIN--(BUSINESS WIRE)-- The "US Uterine Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Uterine Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Uterine Cancer pipeline, epidemiology, market va

DUBLIN--(BUSINESS WIRE)-- The "US Chronic Myeloid Leukemia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Chronic Myeloid Leukemia Market and Competitive Landscape - 2018, provides comprehensive insights into Chronic Myeloid Leukemia

DUBLIN--(BUSINESS WIRE)-- The "US Gastro-Intestinal Stromal Tumor Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Gastro-Intestinal Stromal Tumor Market and Competitive Landscape - 2018, provides comprehensive insights into Gastro-Intestinal Stromal Tum

DUBLIN--(BUSINESS WIRE)-- The "US Squamous Cell Carcinoma Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Squamous Cell Carcinoma Market and Competitive Landscape - 2018, provides comprehensive insights into Squamous Cell Carcinoma pipeline,

DUBLIN--(BUSINESS WIRE)-- The "US Brain Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. US Brain Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Brain Cancer pipeline, epidemiology, market

WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on

DUBLIN--(BUSINESS WIRE)-- The "Global Osteoporosis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Global Osteoporosis Market and Competitive Landscape - 2018, provides comprehensive insights into Osteoporosis pipeline, epidemiology, market valuations,